| Issue |
Section |
Title |
File |
| Vol 22, No 1 (2020) |
Articles |
OPTIMIZATION OF PHARMACOTHERAPY IN A POLYMORBID PATIENT WITH A COMBINATION OF CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE. CLINICAL CASE |
(Rus)
|
| Vol 21, No 12 (2019) |
Articles |
COMBINATION OF COMPONENTS FOR SUSTENANCE OR IMPROVEMENT OF ELDERLY AND SENIOR AGE PATIENTS’ FUNCTIONAL STATUS (ANTI-AGE MEDICINE) |
(Rus)
|
| Vol 21, No 10 (2019) |
Articles |
THE EFFECT OF INDIVIDUAL GROUPS OF DRUGS ON THE RISK OF PROLONGATION OF THE QTC INTERVAL |
(Rus)
|
| Vol 22, No 5 (2020) |
Articles |
How to improve anticoagulant therapy in atrial fibrillation? |
(Rus)
|
| Vol 21, No 12 (2019) |
Articles |
2018 AND 2019 GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION: IS THERE A PLACE FOR UNFIXED DRUG COMBINATIONS? |
(Rus)
|
| Vol 21, No 9 (2019) |
Articles |
DRUG-INDUCED DIZZINESS |
(Rus)
|
| Vol 22, No 5 (2020) |
Articles |
Impact of different medication groups on drug-induced seizures risk |
(Rus)
|
| Vol 23, No 6 (2021) |
Articles |
10 years of ARISTOTLE trial: results and lessons |
(Rus)
|
| Vol 23, No 10 (2021) |
Articles |
Interaction of drugs and coffee |
(Rus)
|
| Vol 21, No 5 (2019) |
Articles |
The clinical implication of the target organ protective properties of antihypertensive drugs in new guidelines for the management of arterial hypertension: the benefit of calcium channel blockers and diuretics |
(Rus)
|
| Vol 21, No 5 (2019) |
Articles |
Drug-induced long QT interval: prevalence, risk factors, treatment and prevention |
(Rus)
|
| Vol 21, No 4 (2019) |
Articles |
Medically induced hypoglycemia: focus on medications not included in the group of antihyperglycemic medications |
(Rus)
|
| Vol 21, No 1 (2019) |
Articles |
The new 2018 European guidelines for the management of arterial hypertension: the most important aspects of use in real-life clinical practice |
(Rus)
|
| Vol 21, No 2 (2019) |
Articles |
Influence of proton pump inhibitors on cognitive function and dementia risk |
(Rus)
|
| Vol 21, No 1 (2019) |
Articles |
Combined therapy with proton pump inhibitors and clopidogrel - focus on cardiovascular risk |
(Rus)
|
| Vol 23, No 12 (2021) |
Articles |
Hepatic impairment as a risk factor of adverse drug reactions |
(Rus)
|
| Vol 24, No 6 (2022) |
Articles |
Cancer treatment and drug-induced QT interval prolongation: A review |
(Rus)
|
| Vol 25, No 5 (2023): Gastroenterology |
Articles |
Gastroprotective therapy in patients with atrial fibrillation receiving anticoagulant therapy: A review |
(Rus)
|
